Skip to content

NSAIDs could help prevent, treat breast cancer

Last Updated: 2008-03-10 13:00:37 -0400 (Reuters Health)
By Anne Harding

What breastcancer.org says about this article…

NSAIDs could help prevent, treat breast cancer

The study reviewed here collected and analyzed results from many earlier studies looking for a link between breast cancer risk and nonsteroidal anti-inflammatory (NSAID) medicines. The researchers concluded that taking NSAIDs might lower breast cancer risk. Still, they weren't certain about the link between NSAIDs and lower risk and strongly emphasized the need for more research.

Aspirin is probably the most common NSAID. Other NSAIDs include Advil, Motrin, Aleve, and Celebrex. NSAIDs are used to treat fever, pain, and inflammation. Many adults take a low dose of aspirin each day to reduce the risk of heart attack and stroke. NSAIDs work by blocking the COX enzyme. The COX enzyme signals the body to develop fever and inflammation, which can cause pain. COX enzyme levels can be abnormally high in people diagnosed with breast cancer and doctors don't understand why this happens. The ability of NSAIDs to block the COX enzyme may be why NSAIDS seem to be associated with lower breast cancer risk.

NSAIDs offer benefits to people who have fever or chronic pain. Aspirin may even save lives. But as with most medicines, NSAIDs can cause side effects, including stomach ulcers and intestinal bleeding. When NSAIDs are taken at higher-than-recommended doses or for a long time, other more serious problems can happen.

Until the link between NSAIDs and reduced breast cancer risk is better understood, DON'T take an NSAID to lower your risk. Even if more research shows that NSAIDs do lower breast cancer risk, it will take some time for doctors to figure out the right type and dose. Always tell your doctor about any and all medicines (including those that don't require a prescription), and any vitamins and supplements that you're taking or thinking about taking. Together you can decide what's best for you.

More Research News on Risk Factors (122 Articles)

NEW YORK (Reuters Health) - Aspirin and related anti-inflammatory drugs may help reduce the risk of breast cancer, and might even have a role in treating the disease, according to a new review of existing research on the topic.

But more research is needed to determine who would benefit the most from the drugs' effects, and to understand how women might be able to take them without suffering harmful side effects such as stomach ulcers, Drs. Ian Fentiman and A. Agrawal from Guy's Hospital in London conclude.

"My take-home message is not go and start taking aspirin," Fentiman told Reuters Health. "We think our review has shown that aspirin can reduce the incidence of breast cancer, but, and a very big but, is that almost certainly this occurs when you take full doses of aspirin and not the small doses that you take for the prevention of heart disease."

Such high doses carry the risk of causing stomach ulcers and related complications, the researcher said. "We just have to look again and say -- what is the way that we could possibly give these agents in safe manner."

In breast cancer, production of the COX enzyme is abnormally high. Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) work by blocking this enzyme, so it is conceivable that they could help prevent or treat breast cancer, Fentiman and Agrawal note.

To investigate, the researchers reviewed several studies of NSAID use and breast cancer risk, and found that the drugs -- especially aspirin -- were tied to a "moderate reduction" in risk of the disease.

The data suggested that the drugs were effective in preventing estrogen receptor-positive tumors, which currently can be prevented and treated with drugs such as tamoxifen.

There also was some evidence that NSAIDs might be effective against tumors that did not carry estrogen receptors. "If that were the case that would be a big plus because at the moment we don't have a way of preventing those cancers, which tend to be the more aggressive ones," Fentiman said.

"NSAIDs may reduce breast cancer risk by 20 percent but the optimal type, dose and duration is still undetermined together with the feasibility of such an intervention in an at-risk population," Fentiman and Agrawal conclude.

SOURCE: International Journal of Clinical Practice, March 2008.


Email Updates

Stay informed about current research, online events, and more.

Please leave this field empty
Back to top

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

Learn more about our commitment to your privacy

© 2009 Breastcancer.org - All rights reserved.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.